Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases.

van Beek, Nina; Dähnrich, Cornelia; Johannsen, Nora; Lemcke, Susanne; Goletz, Stephanie; Hübner, Franziska; Di Zenzo, Giovanni; Dmochowski, Marian; Drenovska, Kossara; Geller, Shamir; Horn, Michael Peter; Kowalewski, Cezary; Medenica, Ljiljana; Murrell, Dedee F; Patsatsi, Aikaterini; Uzun, Soner; Vassileva, Snejina; Zillikens, Detlef; Schlumberger, Wolfgang and Schmidt, Enno (2017). Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases. Journal of the American Academy of Dermatology, 76(5), 889-894.e5. Elsevier 10.1016/j.jaad.2016.11.002

[img] Text
1-s2.0-S019096221631043X-main-1.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (662kB) | Request a copy

BACKGROUND Serologic diagnosis of autoimmune blistering disease (AIBD) usually follows a sophisticated multistep algorithm. OBJECTIVE We sought validation of a multivariant enzyme-linked immunosorbent assay (ELISA) in the routine diagnosis of AIBD. METHODS The multivariant ELISA comprising 6 recombinant immunodominant forms of major AIBD target antigens, ie, desmoglein 1, desmoglein 3, envoplakin, BP180, BP230, and type VII collagen was applied in: (1) a cohort of well-characterized AIBD (n = 173) and control sera (n = 130), (2) a prospective multicenter study with 204 sera from patients with newly diagnosed AIBD with positive direct immunofluorescence microscopy, and (3) a prospective monocenter study with 292 consecutive sera from patients with clinical suspicion of AIBD in comparison with the conventional multistep diagnostic algorithm. RESULTS Concordant results in the multivariant ELISA compared with direct immunofluorescence microscopy were seen in 94% of patients with pemphigus and 71% of patients with pemphigoid (Cohen κ value, 0.95 and 0.66) and with the conventional multistep diagnostic approach in 91% of patients with pemphigus and 88% of patients with bullous pemphigoid and 93% of autoantibody-negative sera (Cohen κ, 0.95, 0.84, and 0.78). LIMITATIONS IgA autoantibodies and less common target antigens were not analyzed. CONCLUSIONS The multivariant ELISA is a practical, highly standardized, and widely available novel diagnostic tool for the routine diagnosis of AIBD.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry

UniBE Contributor:

Horn, Michael Peter

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0190-9622

Publisher:

Elsevier

Language:

English

Submitter:

Marie-Christine Müller

Date Deposited:

18 Apr 2017 14:37

Last Modified:

18 Apr 2017 14:37

Publisher DOI:

10.1016/j.jaad.2016.11.002

PubMed ID:

28038887

Uncontrolled Keywords:

autoantibody; blistering; bullous pemphigoid; epidermolysis bullosa acquisita; pemphigus

BORIS DOI:

10.7892/boris.95555

URI:

https://boris.unibe.ch/id/eprint/95555

Actions (login required)

Edit item Edit item
Provide Feedback